<?xml version="1.0" encoding="UTF-8"?>
<p>Arbidol has only been used with a pharmacological approach and therefore, there are insufficient data on its toxicity to rigorously evaluate its safety in chronic administration. Nevertheless, there are many studies that comment its good tolerability. It is not expensive for third world countries that require effective antiviral therapies. In this pandemic situation there is a clinical trial in progress [
 <xref rid="B72-medicina-56-00386" ref-type="bibr">72</xref>].
</p>
